GENENTA SCIENCE(SP.ADR)/1 (K5F) — Cash Flow-to-Debt Ratio
GENENTA SCIENCE(SP.ADR)/1 (K5F) has a Cash Flow-to-Debt Ratio of -0.68x as of December 2025, meaning its operating cash flow of €-6.87 Million could theoretically repay -1% of its total liabilities (€10.05 Million) in one year. See GENENTA SCIENCE(SP.ADR)/1 current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GENENTA SCIENCE(SP.ADR)/1 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for GENENTA SCIENCE(SP.ADR)/1 across 5 annual periods. Also explore K5F year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for GENENTA SCIENCE(SP.ADR)/1 (2021–2025)
Year-by-year debt coverage analysis for GENENTA SCIENCE(SP.ADR)/1. For market capitalisation and broader financial context, see GENENTA SCIENCE(SP.ADR)/1 (K5F) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.68x | €-6.87 Million | €10.05 Million | ▲ +74.5% |
| 2024 | -2.68x | €-6.24 Million | €2.33 Million | ▲ +54.2% |
| 2023 | -5.85x | €-11.21 Million | €1.91 Million | ▼ -81.4% |
| 2022 | -3.23x | €-7.42 Million | €2.30 Million | ▲ +46.0% |
| 2021 | -5.97x | €-6.96 Million | €1.17 Million | — |